Common Contracts
2 similar Asset Purchase Agreement contracts by Igi Laboratories, Inc
Asset Purchase Agreement between VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS LUXEMBOURG SARL, and IGI LABORATORIES, INC. dated as of September 30, 2014 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • October 1st, 2014 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • New York
THIS ASSET PURCHASE AGREEMENT is entered into as of September 30, 2014 by and between Valeant Pharmaceuticals North America, LLC, a Delaware limited liability company and Valeant Pharmaceuticals Luxembourg SARL, a Luxembourg limited liability company (together, “Seller”), and IGI Laboratories, Inc., a Delaware corporation (“Purchaser”).
Asset Purchase Agreement between VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS LUXEMBOURG SARL, and IGI LABORATORIES, INC. dated as of September 30, 2014 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • October 1st, 2014 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • New York
THIS ASSET PURCHASE AGREEMENT is entered into as of September 30, 2014 by and between Valeant Pharmaceuticals North America, LLC, a Delaware limited liability company and Valeant Pharmaceuticals Luxembourg SARL, a Luxembourg limited liability company (together, “Seller”), and IGI Laboratories, Inc., a Delaware corporation (“Purchaser”).
